BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1458 related articles for article (PubMed ID: 18929625)

  • 1. Roles of hippocampal NMDA receptors and nucleus accumbens D1 receptors in the amphetamine-produced conditioned place preference in rats.
    Tan SE
    Brain Res Bull; 2008 Dec; 77(6):412-9. PubMed ID: 18929625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of hippocampal N-methyl-D-aspartate receptors and calcium/calmodulin-dependent protein kinase II in amphetamine-produced conditioned place preference in rats.
    Sakurai S; Yu L; Tan SE
    Behav Pharmacol; 2007 Sep; 18(5-6):497-506. PubMed ID: 17762518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dorsal and ventral hippocampal NMDA stimulation on nucleus accumbens core and shell dopamine release.
    Peleg-Raibstein D; Feldon J
    Neuropharmacology; 2006 Oct; 51(5):947-57. PubMed ID: 16876207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleus accumbens NMDA receptor activation regulates amphetamine cross-sensitization and deltaFosB expression following sexual experience in male rats.
    Beloate LN; Weems PW; Casey GR; Webb IC; Coolen LM
    Neuropharmacology; 2016 Feb; 101():154-64. PubMed ID: 26391065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal dopamine receptors modulate the motor activation and the increase in dopamine levels in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus.
    Zornoza T; Cano-Cebrián MJ; Miquel M; Aragón C; Polache A; Granero L
    Neuropsychopharmacology; 2005 May; 30(5):843-52. PubMed ID: 15689964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of calcineurin inhibition and protein kinase A activation on nucleus accumbens amphetamine-produced conditioned place preference in rats.
    Gerdjikov TV; Beninger RJ
    Eur J Neurosci; 2005 Aug; 22(3):697-705. PubMed ID: 16101751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Place preference induced by nucleus accumbens amphetamine is impaired by local blockade of Group II metabotropic glutamate receptors in rats.
    Gerdjikov TV; Beninger RJ
    BMC Neurosci; 2006 May; 7():43. PubMed ID: 16734896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cAMP-dependent protein kinase and reward-related learning: intra-accumbens Rp-cAMPS blocks amphetamine-produced place conditioning in rats.
    Beninger RJ; Nakonechny PL; Savina I
    Psychopharmacology (Berl); 2003 Oct; 170(1):23-32. PubMed ID: 12768275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPA/kainate, NMDA, and dopamine D1 receptor function in the nucleus accumbens core: a context-limited role in the encoding and consolidation of instrumental memory.
    Hernandez PJ; Andrzejewski ME; Sadeghian K; Panksepp JB; Kelley AE
    Learn Mem; 2005; 12(3):285-95. PubMed ID: 15930507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens.
    Heidbreder C; Feldon J
    Synapse; 1998 Aug; 29(4):310-22. PubMed ID: 9661249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal dopamine receptors modulate cFos expression in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus.
    Zornoza T; Cano-Cebrián MJ; Martínez-García F; Polache A; Granero L
    Neuropharmacology; 2005 Dec; 49(7):1067-76. PubMed ID: 16040065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Place preference induced by nucleus accumbens amphetamine is impaired by antagonists of ERK or p38 MAP kinases in rats.
    Gerdjikov TV; Ross GM; Beninger RJ
    Behav Neurosci; 2004 Aug; 118(4):740-50. PubMed ID: 15301601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glutamate-dopamine interaction in the persistent enhanced response to amphetamine in nucleus accumbens core but not shell following a single restraint stress.
    Pacchioni AM; Cador M; Bregonzio C; Cancela LM
    Neuropsychopharmacology; 2007 Mar; 32(3):682-92. PubMed ID: 16641941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleus accumbens PKA inhibition blocks acquisition but enhances expression of amphetamine-produced conditioned activity in rats.
    Gerdjikov TV; Giles AC; Swain SN; Beninger RJ
    Psychopharmacology (Berl); 2007 Jan; 190(1):65-72. PubMed ID: 17047929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C; Abraini JH; David HN
    Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mGluR5 activation in the nucleus accumbens is not essential for sexual behavior or cross-sensitization of amphetamine responses by sexual experience.
    Pitchers KK; Di Sebastiano AR; Coolen LM
    Neuropharmacology; 2016 Aug; 107():122-130. PubMed ID: 26946431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate and dopamine in nucleus accumbens core and shell: sequence learning versus performance.
    Bauter MR; Brockel BJ; Pankevich DE; Virgolini MB; Cory-Slechta DA
    Neurotoxicology; 2003 Mar; 24(2):227-43. PubMed ID: 12606295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of conditioned place preference induced by intra-accumbens infusion of amphetamine is attenuated by co-infusion of dopamine D1 and D2 receptor antagonists.
    Liao RM
    Pharmacol Biochem Behav; 2008 May; 89(3):367-73. PubMed ID: 18275994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing roles of nucleus accumbens core and shell dopamine in the modulation of limbic information processing.
    Ito R; Hayen A
    J Neurosci; 2011 Apr; 31(16):6001-7. PubMed ID: 21508225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relief learning requires a coincident activation of dopamine D1 and NMDA receptors within the nucleus accumbens.
    Bergado Acosta JR; Kahl E; Kogias G; Uzuneser TC; Fendt M
    Neuropharmacology; 2017 Mar; 114():58-66. PubMed ID: 27894877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.